Skip to content
sacubitril

Structure via PubChem · Public domain (PubChem)

EntityQ17811448· pop 13· linked from 68 articles

sacubitril

Sign in to save

Also known as AHU377

Sacubitril (; INN) is an antihypertensive drug used in combination with valsartan. The combination drug sacubitril/valsartan, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. It was approved under the FDA's priority review process for use in heart failure on July 7, 2015.

In the Vinony graph

Within Vinony's link graph, sacubitril is referenced by 68 other articles, and connects out to digital object identifier, chemical formula and heart failure.

It sits within the topics Antihypertensive agents, Biphenyls and Butyramides.

Its subject is documented across 12 Wikipedia language editions.

Key facts

Drug.IUPAC_name
4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid
Drug.image
Sacubitril skeletal.svg
Drug.image_class
skin-invert-image
Drug.licence_EU
yes
Drug.CAS_number
149709-62-6
Drug.UNII
17ERJ0MKGI
Drug.ATCvet
149709-62-6
Drug.ATC_prefix
C09
Drug.ATC_suffix
DX04
Drug.ATC_supplemental
(combination with valsartan)
Drug.PubChem
9811834
Drug.DrugBank
DB09292
Drug.ChemSpiderID
7987587
Drug.KEGG
D10225
Drug.synonyms
AHU-377
Drug.C
24
Drug.H
29
Drug.N
1

via Wikipedia infobox

Chemical data

Formula
C24H29NO5
Molecular weight
411.5 g/mol
IUPAC name
4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid
SMILES
CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O
InChIKey
PYNXFZCZUAOOQC-UTKZUKDTSA-N
XLogP
3.7
Polar surface area
92.7 Ų
H-bond donors
2
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2015
Admin. routes
oral
Indications
hypertension, congestive heart failure, heart failure, hypertrophic cardiomyopathy

via ChEMBL · EBI

Wikidata facts

Mass
411.204573
Has use
medication
Show 5 more facts
chemical formula
C₂₄H₂₉NO₅
World Health Organisation international non-proprietary name
sacubitril
isomeric SMILES
CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O
canonical SMILES
CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O
Commons category
Sacubitril
Sources (4)

via Wikidata · CC0

~4 min read

Encyclopedic overview

5 sections
Contents
  • Side effects
  • Mechanism of action
  • Synthesis
  • See also
  • References

{{Infobox drug | drug_name = | IUPAC_name = 4-{[(2S,4R)-1-(4-Biphenylyl)-5-ethoxy-4-methyl-5-oxo-2-pentanyl]amino}-4-oxobutanoic acid | image = Sacubitril skeletal.svg | image_class = skin-invert-image | alt = | caption =

| tradename = | Drugs.com = | MedlinePlus = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | licence_EU = yes | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

Excerpted from Wikipedia’s “sacubitril” article, available under the CC BY-SA 4.0 licence.

Gallery (3)

Connections

Categories